View Item 

Show simple item record

Costly choices for treating Wilson's disease

dc.contributor.authorSchilsky, Michael L.en_US
dc.contributor.authorRoberts, Eve A.en_US
dc.contributor.authorHahn, Sihounen_US
dc.contributor.authorAskari, Fredericken_US
dc.date.accessioned2015-04-02T15:12:36Z
dc.date.available2016-05-10T20:26:28Zen
dc.date.issued2015-04en_US
dc.identifier.citationSchilsky, Michael L.; Roberts, Eve A.; Hahn, Sihoun; Askari, Frederick (2015). "Costly choices for treating Wilson's disease." Hepatology 61(4): 1106-1108.en_US
dc.identifier.issn0270-9139en_US
dc.identifier.issn1527-3350en_US
dc.identifier.urihttps://hdl.handle.net/2027.42/110871
dc.publisherWiley Periodicals, Inc.en_US
dc.titleCostly choices for treating Wilson's diseaseen_US
dc.typeArticleen_US
dc.rights.robotsIndexNoFollowen_US
dc.subject.hlbsecondlevelInternal Medicine and Specialtiesen_US
dc.subject.hlbtoplevelHealth Sciencesen_US
dc.description.peerreviewedPeer Revieweden_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/110871/1/hep27663.pdf
dc.identifier.doi10.1002/hep.27663en_US
dc.identifier.sourceHepatologyen_US
dc.identifier.citedreferenceFerenci P, Czlonkowska A, Stremmel W, Houwen R, Rosenberg W, Schilsky M, et al. EASL Clinical Practice Guidelines: Wilson's disease. J Hepatol 2012; 56: 671 ‐ 685.en_US
dc.identifier.citedreferenceBrewer GJ, Yuzbasiyan‐Gurkan V, Johnson V, Dick RD, Wang Y. Treatment of Wilson's disease with zinc XII: dose regimen requirements. Am J Med Sci 1993; 305: 199 ‐ 202.en_US
dc.identifier.citedreferenceQuotes for cost of medications. Available at: http://Rxpricequotes.com. Accessed October 30, 2014.en_US
dc.identifier.citedreferenceSeoane‐Vazquez E, Rodriguez‐Monguio R, Szeinbach SL, Visaria J. Incentives for orphan drug research and development in the United States. Orphanet J Rare Dis 2008; 3: 33.en_US
dc.identifier.citedreferenceChandok N, Roberts EA. The trientine crisis in Canada: a call to advocacy. Can J Gastroenterol Hepatol 2014; 28: 184.en_US
dc.identifier.citedreferenceNocera J. The $300,000 drug. The New York Times, July 18, 2014.en_US
dc.identifier.citedreferenceReardon S. Regulators adopt more orphan drugs. Nature 2014; 508: 17 ‐ 18.en_US
dc.identifier.citedreferenceBrewer GJ, Dick RD, Johnson VD, Brunberg JA, Kluin KJ, Fink JK. Treatment of Wilson's disease with zinc: XV long‐term follow‐up studies. J Lab Clin Med 1998; 132: 264 ‐ 278.en_US
dc.identifier.citedreferenceHoogenraad TU. Paradigm shift in treatment of Wilson's disease: zinc therapy now treatment of choice. Brain Dev 2006; 28: 141 ‐ 146.en_US
dc.identifier.citedreferenceRoberts EA, Schilsky ML. Diagnosis and treatment of Wilson disease: an update. Hepatology 2008; 47: 2089 ‐ 2111.en_US
dc.identifier.citedreferenceLinn FH, Houwen RH, van Hattum J, van der Kleij S, van Erpecum KJ. Long‐term exclusive zinc monotherapy in symptomatic Wilson disease: experience in 17 patients. Hepatology 2009; 50: 1442 ‐ 1452.en_US
dc.identifier.citedreferenceWiggelinkhuizen M, Tilanus ME, Bollen CW, Houwen RH. Systematic review: clinical efficacy of chelator agents and zinc in the initial treatment of Wilson disease. Aliment Pharmacol Ther 2009; 29: 947 ‐ 958.en_US
dc.identifier.citedreferenceWeiss KH, Gotthardt DN, Klemm D, Merle U, Ferenci‐Foerster D, Schaefer M, et al. Zinc monotherapy is not as effective as chelating agents in treatment of Wilson disease. Gastroenterology 2011; 140: 1189 ‐ 1198.e1.en_US
dc.identifier.citedreferenceMedici V, Trevisan CP, D'Incà R, Barollo M, Zancan L, Fagiuoli S, et al. Diagnosis and management of Wilson's disease: results of a single center experience. J Clin Gastroenterol 2006; 40: 936 ‐ 941.en_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
hep27663.pdf
Size:
335.3KB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.